Interleukin-10 receptor expression and signalling were down-regulated in CD4 + T cells of lupus nephritis patients

Clinical and Experimental Immunology

Volumn 165, Issue 2, 2011, Pages 163-171

  Cui, H D ^a   Qi, Z M ^a   Yang, L L ^a   Qi, L ^a   Zhang, N ^a   Zhang, X L ^a   Du, S Y ^a   Jiang, Y ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Interleukin 10 receptor; Lupus nephritis; Signal transduction; STAT 3 transcription factor; Systemic lupus erythematosus

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 10 RECEPTOR 1; INTERLEUKIN 2; INTERLEUKIN 6; STAT1 PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

ADOLESCENT; ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; DOWN-REGULATION; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; PHOSPHORYLATION; RECEPTORS, INTERLEUKIN-10; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR;

EID: 79960065473     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04424.x     Document Type: Article

References (40)

1. Crow MK. Collaboration, genetic associations, and lupus erythematosus. N Engl J Med 2008; 358:956-61.
2. Groux H, Cottrez F. The complex role of interleukin-10 in autoimmunity. J Autoimmun 2003; 20:281-5.
3. Llorente L, Richaud-Patin Y, Wijdenes J etal. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur Cytokine Netw 1993; 4:421-7.
4. Llorente L, Richaud-Patin Y, Fior R etal. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum 1994; 37:1647-55.
5. Llorente L, Zou W, Levy Y etal. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 1995; 181:839-44.
6. Gelati M, Lamperti E, Dufour A etal. IL-10 production in multiple sclerosis patients, SLE patients and healthy controls: preliminary findings. Ital J Neurol Sci 1997; 18:191-4.
7. Gröndal G, Kristjansdottir H, Gunnlaugsdottir B etal. Increased number of interleukin-10-producing cells in systemic lupus erythematosus patients and their first-degree relatives and spouses in Icelandic multicase families. Arthritis Rheum 1999; 42:1649-54.
8. Houssiau F, Lefebvre C, Vanden Berghe M, Lambert M, Devogelaer J, Renauld J. Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus 1995; 4:393-5.
9. Park YB, Lee SK, Kim DS, Lee J, Lee CH, Song CH. Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 1998; 16:283-8.
10. Miret C, Font J, Molina R etal. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus. Anticancer Res 2001; 21:3053-9.
11. Yin Z, Bahtiyar G, Zhang N etal. IL-10 regulates murine lupus. J Immunol 2002; 169:2148-55.
12. Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, Tedder TF. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008; 28:639-50.
13. Blair PA, Noreña LY, Flores-Borja F etal. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 2010; 32:129-40.
14. Haas KM, Watanabe R, Matsushita T etal. Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice. J Immunol 2010; 184:4789-800.
15. Watanabe R, Ishiura N, Nakashima H etal. Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J Immunol 2010; 184:4801-9.
16. Donnelly RP, Dickensheets H, Finbloom DS. The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J Interferon Cytokine Res 1999; 19:563-73.
17. Qi ZM, Wang J, Sun ZR etal. Polymorphism of the mouse gene for the interleukin 10 receptor alpha chain (IL-10ra) and its association with the autoimmune phenotype. Immunogenetics 2005; 57:697-702.
18. Cairns AP, Crockard AD, Bell AL. Interleukin-10 receptor expression in systemic lupus erythematosus and rheumatoid arthritis. Clin Exp Rheumatol 2003; 21:83-6.
19. Valencia-Pacheco G, Layseca-Espinosa E, Niño-Moreno P etal. Expression and function of IL-10R in mononuclear cells from patients with systemic lupus erythematosus. Scand J Rheumatol 2006; 35:368-78.
20. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40:1725.
21. Bombardier C, Gladman D, Urowitz M, Caron D, Chang C. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35:630-40.
22. Niemand C, Nimmesgern A, Haan S etal. Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3. J Immunol 2003; 170:3263-72.
23. Williams LM, Sarma U, Willets K, Smallie T, Brennan F, Foxwell BM. Expression of constitutively active STAT3 can replicate the cytokine-suppressive activity of interleukin-10 in human primary macrophages. J Biol Chem 2007; 282:6965-75.
24. Kariuki SN, Niewold TB. Genetic regulation of serum cytokines in systemic lupus erythematosus. Transl Res 2010; 155:109-17.
25. Lit LC, Wong CK, Tam LS, Li EK, Lam CW. Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus. Ann Rheum Dis 2006; 65:209-15.
26. Inghirami G, Simon J, Balow JE, Tsokos GC. Activated T lymphocytes in the peripheral blood of patients with systemic lupus erythematosus induce B cells to produce immunoglobulin. Clin Exp Rheumatol 1988; 6:269-76.
27. Wada T, Schwarting A, Chesnutt MS, Wofsy D, Rubin Kelley V. Nephritogenic cytokines and disease in MRL-Fas(lpr) kidneys are dependent on multiple T-cell subsets. Kidney Int 2001; 59:565-78.
28. Tucci M, Stucci S, Strippoli S, Silvestris F. Cytokine overproduction, T-cell activation, and defective T-regulatory functions promote nephritis in systemic lupus erythematosus. J Biomed Biotechnol 2010; 2010:457146.
29. Daikh DI, Finck BK, Linsley PS, Hollenbaugh D, Wofsy D. Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways. J Immunol 1997; 159:3104-8.
30. Fiorentino D, Zlotnik A, Mosmann T, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147:3815-22.
31. Fiorentino D, Zlotnik A, Vieira P etal. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991; 146:3444-51.
32. Lentsch AB, Shanley TP, Sarma V, Ward PA. In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13. J Clin Invest 1997; 100:2443-8.
33. Eo SK, Chun S, Lee S, Rouse BT. On the mechanisms of T cell silencing by IL-10 DNA: direct and indirect inhibition of T cell functions. Cell Immunol 2000; 206:59-69.
34. Buer J, Lanoue A, Franzke A, Garcia C, von Boehmer H, Sarukhan A. Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo. J Exp Med 1998; 187:177-83.
35. Ding Y, Qin L, Zamarin D etal. Differential IL-10R1 expression plays a critical role in IL-10-mediated immune regulation. J Immunol 2001; 167:6884-92.
36. Cassatella MA, Gasperini S, Bovolenta C etal. Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: evidence for an IL-10-induced pathway that is independent of STAT protein activation. Blood 1999; 94:2880-9.
37. Crepaldi L, Gasperini S, Lapinet JA etal. Up-regulation of IL-10R1 expression is required to render human neutrophils fully responsive to IL-10. J Immunol 2001; 167:2312-22.
38. Liu Y, Wei S, Ho A, de Waal Malefyt R, Moore K. Expression cloning and characterization of a human IL-10 receptor. J Immunol 1994; 152:1821-9.
39. Gasche C, Grundtner P, Zwirn P etal. Novel variants of the IL-10 receptor 1 affect inhibition of monocyte TNF-alpha production. J Immunol 2003; 170:5578-82.
40. Hermann J, Gruber S, Neufeld JB etal. IL10R1 loss-of-function alleles in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Rheumatol 2009; 27:603-8.